Fate Therapeutics

In News

Fate Therapeutics (NASDAQ:FATE) Share Price Passes Below 200-Day Moving Average - Here's What Happened - MarketBeat

MarketBeat - Mar 31, 2026

Vanguard (FATE) reports 0 shares after internal realignment - Stock Titan

Stock Titan - Mar 26, 2026

Companies Like Fate Therapeutics (NASDAQ:FATE) Could Be Quite Risky - Yahoo Finance

Yahoo Finance - Dec 21, 2025

Mizuho reiterates Fate Therapeutics stock rating on trial progress - Investing.com

Investing.com - Mar 24, 2026

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

GlobeNewswire - Mar 04, 2026

Fate Therapeutics Inc Stock: Pioneering iPSC Cell Therapies Amid Biotech Volatility - AD HOC NEWS

AD HOC NEWS - Mar 31, 2026

Biotech layoffs: Fate, Generation Bio, ORIC trim teams and pipelines - FirstWord Pharma

FirstWord Pharma - Aug 13, 2025

Fate Therapeutics FY 2025 Loss Reduction Tests Bullish Narratives On Path To Profitability - simplywall.st

simplywall.st - Feb 27, 2026

Fate Therapeutics (FATE) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance

Yahoo Finance - Feb 26, 2026

FATE SEC Filings - Fate Therapeutic 10-K, 10-Q, 8-K Forms - Stock Titan

Stock Titan - Mar 16, 2026

Fate Therapeutics, Inc. (NASDAQ:FATE) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat

MarketBeat - Mar 23, 2026

Fate Therapeutics to Participate in Leerink Partners 2026 Global Healthcare Conference - GlobeNewswire

GlobeNewswire - Mar 03, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment